<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04991714</url>
  </required_header>
  <id_info>
    <org_study_id>706014-1</org_study_id>
    <nct_id>NCT04991714</nct_id>
  </id_info>
  <brief_title>Effect of Sweetness Intensity of a Sucrose Solution on Blood Glucose Regulation and Energy Intake</brief_title>
  <official_title>Einfluss Der Süßintensität Einer Saccharose-Lösung Auf Die Blutglukoseregulation Und Energieaufnahme in Gesunden Männern</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to investigate the influence of the modulation of the&#xD;
      sweetness intensity of a carbohydrate (sucrose)-containing solution on metabolic effects, in&#xD;
      particular the regulation of blood glucose concentration and regulation of hunger &amp; satiety.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is designed as a randomised cross-over intervention study with four interventions.&#xD;
      The study investigates the influence of sweetness modulation by Rebaudioside M (sweetness&#xD;
      enhancement) and Lactisol (sweetness inhibition) of a 10% sucrose solution, corresponding to&#xD;
      the concentration of a regular soft drink, on blood glucose regulation (blood glucose&#xD;
      concentration and regulating hormones) in healthy male volunteers. Furthermore, the study&#xD;
      assesses ad libitum energy intake, individual feelings of hunger and satiety, metabolic&#xD;
      responses to the interventions, and preference for sweet-tasting foods such as sugar and&#xD;
      sweeteners. In addition, the participants' individual thresholds for sweet taste, as well as&#xD;
      morphological markers for taste sensitivity and body composition will be recorded as&#xD;
      potential influencing factors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 5, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood glucose concentration</measure>
    <time_frame>over a time span of 120 minutes after drinking the test solution</time_frame>
    <description>Glucose concentration [mg/dL] in plasma samples before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin concentration</measure>
    <time_frame>over a time span of 120 minutes after drinking the test solution</time_frame>
    <description>Insulin concentration [mmol/L] in plasma samples before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution</description>
  </primary_outcome>
  <primary_outcome>
    <measure>GLP-1 concentration</measure>
    <time_frame>over a time span of 120 minutes after drinking the test solution</time_frame>
    <description>Glucagon-like peptide 1 concentration in plasma samples [mmol/L] before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution</description>
  </primary_outcome>
  <primary_outcome>
    <measure>GIP-concentration</measure>
    <time_frame>over a time span of 120 minutes after drinking the test solution</time_frame>
    <description>Gastric inhibitory polypeptide concentration in plasma samples [mmol/L] before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Food intake</measure>
    <time_frame>120 minutes after drinking of the test solution</time_frame>
    <description>Ad libitum Food intake from a standardized breakfast</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic changes</measure>
    <time_frame>over a time span of 120 minutes after drinking the test solution</time_frame>
    <description>Metabolome analysis in plasma samples [mmol/L] before, and 15, 30, 60, 90, and 120 minutes after drinking the test solution</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Blood Glucose, Low</condition>
  <condition>Hunger</condition>
  <arm_group>
    <arm_group_label>Sucrose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10% solution in water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sucrose + Reb M</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10% sucrose + 60 mg/L Rebaudioside M</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sucrose + Lactisole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10% sucrose + 30 mg/ L Lactisole</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sucrose + Reb M + Lactisole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10% sucrose + 60 mg/L Rebaudioside M + 30 mg/ L Lactisole</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactisole</intervention_name>
    <description>sweet taste inhibitor (decreases sweetness)</description>
    <arm_group_label>Sucrose + Lactisole</arm_group_label>
    <arm_group_label>Sucrose + Reb M + Lactisole</arm_group_label>
    <other_name>2-(4-methoxyphenoxy)propionic acid</other_name>
    <other_name>CAS Number: 150436-68-3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rebaudioside M</intervention_name>
    <description>Sweetener (increases sweetness)</description>
    <arm_group_label>Sucrose + Reb M</arm_group_label>
    <arm_group_label>Sucrose + Reb M + Lactisole</arm_group_label>
    <other_name>CAS Number: 1220616-44-3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sucrose</intervention_name>
    <description>10% Sucrose corresponding to a regular soft drink</description>
    <arm_group_label>Sucrose</arm_group_label>
    <arm_group_label>Sucrose + Lactisole</arm_group_label>
    <arm_group_label>Sucrose + Reb M</arm_group_label>
    <arm_group_label>Sucrose + Reb M + Lactisole</arm_group_label>
    <other_name>table sugar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male&#xD;
&#xD;
          -  healthy&#xD;
&#xD;
          -  non-smoking&#xD;
&#xD;
          -  normal taste responses towards sweet taste&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  female&#xD;
&#xD;
          -  regular smokers&#xD;
&#xD;
          -  disturbed glucose and/or lipid metabolism&#xD;
&#xD;
          -  regular intake of medication&#xD;
&#xD;
          -  known allergies against one of the test compounds&#xD;
&#xD;
          -  ageusia&#xD;
&#xD;
          -  alcohol or drug addiction&#xD;
&#xD;
          -  intake of antibiotics within the past 2 months&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Lieder, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Lieder, PhD</last_name>
    <phone>+431427770611</phone>
    <email>Barbara.Lieder@univie.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Christian Doppler Laboratory for Taste Research</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Lieder, PhD</last_name>
      <phone>+431427770611</phone>
      <email>Barbara.Lieder@univie.ac.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 19, 2021</study_first_submitted>
  <study_first_submitted_qc>August 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vienna</investigator_affiliation>
    <investigator_full_name>Barbara Lieder</investigator_full_name>
    <investigator_title>Deptuy Head Department of Physiological Chemistry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

